tirzepatide nad+ cyanocobalamin Compounded – BloomMD Personalized Compounded Tirzepatide | Alan

At week 52, tirzepatide demonstrated superior results compared to dulaglutide, with significant reductions in HbA1c levels

These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication

Tirzepatide is a medication originally developed to treat type 2 diabetes, which has also shown outstanding potential in assisting patients with weight management

December 5, 2025

The results were as follows: Weekly tirzepatide 5 mg: -15.0% weight reduction from baseline weight Weekly tirzepatide 10 mg: -19.5% weight reduction from baseline weight Weekly tirzepatide 15 mg: -20.9% weight reduction from baseline weight Placebo: -3.1% weight reduction from baseline weight Note: Even body weight reductions of 5-10% from baseline body weight in obese or overweight individuals can result in big benefits, including improvements in systolic blood pressure and diastolic blood pressure, cholesterol, and blood sugar

Nausea Diarrhea Vomiting Constipation Abdominal pain Headache Fatigue Dyspepsia Dizziness Abdominal distension Eructation Hypoglycemia in patients with type 2 diabetes Flatulence Gastroenteritis Gastroesophageal reflux disease You are encouraged to report negative side effects of prescription products: Contact FDA MedWatch at 1-800-FDA-1088 or visit www.fda.gov/medwatch